Introduction
Sugar-nucleoside diphosphates (sugar-nucleotides) are imperative to carbohydrate metabolism and glycoconjugate biosynthesis. They are composed of an activated sugar donor that is glycosylated onto a diverse range of acceptors, 1 typified by glycosyltransferase catalysed processes for the assembly of glycosides and oligo-or poly-saccharides. 2 They are of considerable interest as carbohydrate-based tools for the study of glycoconjugate biosynthesis and for their potential as enzyme inhibitors in therapeutic intervention strategies. 3 In addition, they are requisite for unambiguous biochemical assay development and for the provision of structurally defined homogenous analytical standards. Thorough reviews concerning chemical 4 and enzymatic 5 methods for sugar-nucleotide synthesis were completed almost a decade ago along with recent reviews of nucleotide, 6 pyrophosphate analogue 7 and phosphate ester/anhydride synthesis. 7, 8 We seek here to update this exciting branch of glycoscience and present a current state of the art (2009-onwards) for the chemical synthesis of natural and mimetic sugar-nucleotides.
Synthetic approaches towards sugar-nucleotides
Sugar-nucleotide's are structurally diverse, consisting of a sugar linked to a nucleoside diphosphate (sugar nucleoside monophosphates, such as CMP-sialic acid, are not covered here). Figure 1 illustrates a generic sugar-nucleotide, alongside two common methodologies for their chemical synthesis. Disconnection approaches have focused on the phosphate linkage between the sugar and nucleoside components, most commonly favouring pyrophosphorylation using a sugar-1-phosphate (sugar-1-P) and an activated nucleoside monophosphate (NMP) (Figure 1, pathway b) . Sugar-nucleotides have also been prepared via direct glycosylation using a nucleoside diphosphate (NDP) with a glycosyl donor 4, 9 ( Figure 1 , pathway a).
In animal cells the most commonly occurring sugar-nucleotides utilise a uridine or guanidine-containing nucleoside diphosphate (UDP or GDP) along with a sugar; this includes aldopentose (UDP-Xyl), aldohexose (UDP-Glc, UDP-Gal), aldohexosamine (UDP-GlcNAc, UDP-GalNAc) and uronic acid (UDP-GlcA) components. These common mammalian examples are illustrated in Figure 1 c) , alongside some examples found in bacteria, such as GDP-ManA, UDP-Galf and dTDP-L-Rha.
In recent years, chemical approaches to synthesise sugar-nucleotides have favoured a P V -P V pyrophosporylation coupling, alongside effective P V -P III coupling chemistries. 10 In this mini-review we first discuss recent advances towards the synthesis of anomeric sugar-1-Ps, followed by diphosphate-forming approaches to the parent sugar-nucleotide. Figure 1 . Approaches to sugar-nucleotides: a) direct glycosylation strategy with a nucleoside diphosphate and glycosyl donor b) pyrophosphorylation using a sugar-1-P and nucleoside monophosphate. LG = leaving group, R = H/OH, Base = heterocycle (C, U, T, G, A), X = phosphate or diphosphate counter ion c) representative examples of common mammalian and bacterial sugar-nucleotides. Figure 2 illustrates some of the different approaches that have been introduced since 2009 for the synthesis of sugar-1-Ps with an α-anomeric configuration. This constitutes an important development within the field, whereby a range of conditions, high yields and good anomeric selectivity now compliment the diverse substrate scope that glycosyl-1-Ps represent for native and mimetic sugar-nucleotide access and evolves from more traditional methods, such as Macdonald phosphorylation. 11 Generally beginning from a hemi-acetal, sugar-1-P's can be obtained from several different phosphorous sources, either directly at the P V oxidation level or using a P III approach, followed by oxidation. These are discussed first, followed by access from alternative anomeric substituents.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT c) representative mammalian and bacterial sugar-nucleotides
Janda et al. 12 synthesised α,β-GalNAz-1-phosphate 1 as part of their approach towards UDP-GalNAz (see Scheme 11) . The group treated α,β-GalNAz-1-OH with salicyl chlorophosphite, followed by aqueous hydrolysis of the resultant cyclic phosphite to deliver a P III species, which was oxidized with I 2 to deliver 1 in 62% yield over three steps (Figure 2 , option 1). Sun and co-workers 13 synthesised α-1-phosphates of L-Rha 2 and L-M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
6dTal 3 using a two-stage approach again starting at P III ( Figure 2 , option 2). Hemi-acetal phosphitylation with triimidazole phosphite (PIm 3 ) and subsequent basic hydrolysis (Et 3 N/H 2 O) delivered sugar-1-H-phosphonate monoesters in 93-95% yield. The 1-Hphosphonates were then converted to silylated phosphite triesters using N,O-bis(trimethylsilyl)acetamaide (BSA), followed by oxidation under basic conditions (I 2 /Et 3 N) to deliver the P V products in 87-89% yield. The group noted that the basic oxidation conditions for the second stage were essential to counter the TMSI generated upon silyl phosphite ether cleavage and prevent unwanted degradation of the product.
Linhardt's group 14 recently reported their chemical synthesis of fluorinated mimetic sugar-nucleotides (see Scheme 7), whereby the group accessed the required sugar-1-Ps through deprotonation of the hemi-acetal (using LDA) and reaction with the electrophilic P V reagent, tetrabenzylpyrophosphate. This furnished the desired α-linked phosphates 4 and 5 in very good yields (72% for 4 and 77% for 5) and excellent α-selectivity (Figure 2, option 3) . Liu et al 15 took an alternative approach when synthesizing the glycosyl-1-phosphate precursor of GDP-α-D-octose, necessary for elucidation of the biosynthesis of a clinically useful antibiotic, Lincomycin A. Using a hemi-acetal as the nucleophile, the group employed the phosphoramidite reagent i Pr 2 N(OBn) 2 and 1-H-tetrazole activation, followed by oxidation of the phosphite to P V , using m-CPBA, delivering α-D-octose-1-phosphate 6 in 23% yield, over three steps (Figure 2 , option 4). Meier and co-workers 16 also used the same phosphoramidite reagent in combination with 4,5-dicyanoimidazole (DCI), followed by oxidation, to synthesise a series of protected 2-fluorinated sugar-1-P's 7-9 in good yields (57-83%, Scheme 1) and, in the case of mannose derivative 9, with complete α-selectivity. The Liu group 17 utilised the P V reagent dibenzyl phosphorochloridate to achieve anomeric phosphorylation in their synthesis of fluorinated sugar-nulceotide mimetics (see Schemes 8 and 9), which they achieved using an oxidative chlorination step, combining P III dibenzyl-1-H-phosphonate and N-chlorosuccinamide (Figure 2 , option 5). Starting from the anomeric hemi-acetal, deprotonation with n BuLi and subsequent reaction with the P V phosphorochloridate afforded the desired Bn-protected-1-phosphate 10 in 48% yield (2 steps, including formation of the phosphorochloridate) and exclusive α-selectivity. Zhou's group 18 synthesised a series of O-4-substituted 2,3,6 trideoxy-L-rhodinose-1-phosphates by first converting the hemi-acetal to the corresponding glycosyl chloride ( Figure  2 , option 6). They achieved this using oxalyl chloride, interestingly noting a faster decomposition of the chloride for 4-position electron donating substituents, such as OTBS, and rationalising this as contributing a destabilising effect upon the oxocarbenium ion intermediate. Phosphorylation was effected using tetra-N-butylammonium hydrogen phosphate for nucleophilic substitution in acceptable yields (35-48%, for 11-13) and furnishing α/β mixtures. The group proposed that the anomeric ratio of the product sugar-1-Ps correlated to the size of the substituent on O-4, with OTBS displaying the lowest preference for the β-anomer compared with OMe or OAc.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Lowary et al 19 recently sought a series of methoxy and deoxy GDP-Man derivatives and in doing so explored the substrate tolerance of a GDP-mannose pyrophosphorylase from Salmonella enterica towards a selection of non-native mannose sugar 1-Ps. From the ethyl thioglycoside the group installed dibenzylphosphate using NIS/AgOTf activation conditions and obtained the series of protected Man-1-P derivatives 14-18 in good yields (67-84%, Scheme 2). The anomeric stereochemistry for the group's series of sugar-1-Ps was confirmed by the size of the 1 J C1-H1 coupling constant, which was 177.9 Hz for 14, consistent with α-stereochemistry.
Scheme 2. Synthesis of 2-, 3-, 4-, 6-O-methyl and 6-deoxy protected Man-1-P derivatives 14-18. i) HO-P(O)(OBn) 2 , NIS, AgOTf, DCM.
The group also installed α-anomeric phosphates onto protected 2-azido-2-deoxy-α-Dgalactofuranose 19 (Scheme 3). 20 Starting from the corresponding glycosyl bromide (obtained using TiBr 4 from the anomeric acetate) and using protected phosphates (dibenzyl to access 2-NHAc species and diallyl to access 2-N 3 ) they obtained good α-selectivity and intriguingly noted a higher diastereoselection for the dibenzyl phosphate system (5:1, α:β) vs diallyl (3:1, α:β). Finally, the Nitz group 21 recently introduced a protecting-group-free synthesis of glycosyl-1-Ps (Scheme 4). Following β-selective formation of N'-glycopyranosylsulfonohydrazide (GSH 22 ) donors in excellent yields, subsequent oxidation of the GSH using CuCl 2 in the presence of a coordinating ligand (2-methyl-2-oxazoline) and nucleophilic phosphoric acid delivered α-enriched-sugar 1-P's in respectable yields (45-64%) across a range of hexoses and, importantly, a disaccharide example in 73% yield. 
β β β β-linked sugar-1-phosphates
Less accessible by conventional methods, due to their lack of thermodynamic anomeric stabilisation, β-linked sugar-1-phosphates are nonetheless required for the construction of β-linked sugar-nucleotides; which play critical roles, for example, as donor substrates for the biosynthesis of bacterial cell wall and LPS components. Vincent and coworkers 23 reported a novel approach to the synthesis of β-phosphoryl-6-azido mannose 22, which can be used in a azide-alkyne cycloaddition reactions (Scheme 5). The group employed the electrophilic P V reagent diallyl chlorophosphate which was added slowly (1.6 mL/h) to the lactol nucleophile source, encouraging reaction with the more nucleophilic equatorial OH, and delivering 22 in good yield (61%) and excellent β-selectivity (1:20, α:β). The regent diallyl chlorophosphate is not commercially available and the authors also reported a convenient method for its synthesis and subsequently demonstrated the scope of their approach towards substituted mannose derivatives, D-Glc, D-Gal, L-Fuc and lactose. Soulère et al 24 have also recently shown that using a P III tri-O-allyl phosphite/I 2 system, in place of P V diallyl chlorophosphate, successfully synthesised β-1-phosphate derivatives of per-O-acyl D-Glc and D-Gal with comparable yields and selectivity.
Fujimoto et al 25 used a Mitsunobu approach to install an anomeric β-1-phosphate in their synthesis of protected D-glycero-D-manno-heptose-1,7-bisphosphate 24 (Scheme 6). The group used dibenzylphosphate as the nucleophile with a DEAD/Et 3 N/ n Bu 3 P reagent combination, obtaining 24 in good yield (56%), although with only a marginal anomeric selectivity (2:3, α:β). At the same time the group of Zamyatina 26 were also effecting a synthesis of alternatively protected D-manno-heptose 23, where the workers here chose to use a slow addition (0.5 equiv./h) of diphenyl phosphorochloridate to achieve better anomeric selectivity, delivering 23 (1:4, α:β) in 51% yield (Scheme 6). 
Chemical synthesis of sugar-nucleotides

Pyrophosphorylation approaches
The second half of this mini-review focuses on developments in the coupling of sugar-1-P's with activated NMP derivatives. The seminal work of Khorana 27 is still widely applied, alongside Wong's 1-H-tetrazole modification. 28 However, exciting advances beyond this classical phosphomorpholidate strategy have been made: a notable example being developments in phosphorimidazolide strategies. 20, 23, 29, 30 A summary of the general approach for coupling NMP's with sugar-1-Ps is shown in Figure 3 , alongside some of the challenges inherent to their chemical synthesis. LG = phospho-leaving group such as morpholine. X = sugar-nucleotide counter-ion; most commonly the di-Na + form is isolated (and stored) using an appropriate anion exchange resin.
Pyrophosphorylation using phosphomorpholidates and phosphopiperidates
Linhardt et al 14 recently investigated the synthesis of non-natural UDP-donors and their use for the construction of chain terminated glycosaminoglycans (GAG's). Their synthesis of UDP-4F-GlcNAc 25 and UDP-4F-GalNAc 26 mimetics required modification at C4, the native position for GAG chain extension. As such, C4-F pyranose monophosphates 4 and 5 were utilised in 1-H-tetrazole catalysed pyrophosphorylation with UMP-morpholidate to deliver 25 and 26 in acceptable yields (Scheme 7). The group noted that purification of the target compounds was initially hampered by the presence of organic phosphate salts, but that these could be successfully removed by conversion of all phosphates to their sodium form and purification using BioGel PS SEC. Application of the mimetic tools demonstrated that 25 was successfully transferred to the non-reducing terminus of heparosan tetra-and hexasaccharides using PmHS1 catalysis and established proof of concept for modulating GAG chain length with mimetic sugar-nucleotides. Liu and co-workers 17 also investigated the synthesis of mimetic sugar-nucleotides to study the mechanism of action of UDP-galactopyranose mutase (UGM), an important enzyme for pathogenic bacteria that converts UDP-Galp to UDP-Galf and, due to its absence in mammalian systems, is a potential target for anti-microbial therapeutic intervention. Their route prepared uridine 5'-diphosphate-5-fluorogalactopyranose (UDP-5F-Galp) 29 by applying Coward's epoxide fluoridolysis strategy. 31 A synthesis starting from methyl-α-Dgalactopyranoside afforded exo olefin 27 and the pivotal fluorohydrin 28 was accessed via in situ epoxidation with DMDO, followed by ring opening with HF to deliver the target D-sugar in excess over its L-isomer (Scheme 8). Coupling of 28 with UMP-morpholidate using 1-Htetrazole provided 29 in 10% yield over three steps from 28. C5-F mimetic 29 was shown to form a substrate-co-factor adduct with reduced FAD, facilitated by UGM and hydrolysing 29.
The key premise of a C5-F was then invoked to form a gem-fluorohydrin at C5, which irreversibly expelled HF, forming a C5-oxo species which prevented the reverse enzymatic pathway to Galp and confirmed further evidence towards the mechanism of action for UGM. Zhou's group 18 reported a synthesis of 4-substituted L-rhodinose sugar-nucleotides using glycosyl monophosphates and NMP-morpholidates in the presence of 1-H-tetrazole (Scheme 10). Deoxysugar-nucleotides are generally considered a more challenging synthetic target as the removal of electron-withdrawing ring hydroxyls renders the positively charged oxocarbenium intermediate more stable: conferring a higher propensity towards hydrolytic cleavage. To this end the group used their sugar-nucleotides 33-36 to conclude that the stability of these compounds was maximised in elevated buffer pH (≥7) at 5 o C and O-4 substitution (TBS, Me, Ac) improved hydrolytic stability, as did the kinetically more stable α-form. Their work gave insight for the use of such sugar-nucleotides to probe relevant biological pathways and their potential for chemoenzymatic applications in natural product synthesis. The Janda group 12 recently described their efficient synthetic method to an azidemodified sugar-nucleotide: UDP-N-azidoacetylgalactosylamine 37 (UDP-α,β-GalNAz). The coupling reaction of sugar-1-P 1 with UMP-morpholidate in the presence of 1-H-tetrazole as catalyst, followed by deacylation delivered mimetic 37 in 87% yield over 2 steps (Scheme 11). UDP-GalNAc 37 was utilised as a tool for the development of site specific antibody drug conjugates, loading azide 37 onto an antibody using a recombinant galactosyltransferase and The work reported by Janda's group can be compared with that reported by Kahne et al, 32 who examined the use of N-methylimidazolium chloride (NMI⋅HCl) as a catalyst for the synthesis of 37, instead of 1-H-tetrazole used by Janda. They concluded that NMI was superior in terms of activity, cost and safety and reduced the pyrophosphate coupling reaction time of GalNAz-1-phosphate 1 with UMP-phosphomorpholidate from three days (using 1-Htetrazole) to 12 h using NMI⋅HCl. They also reported that the yield of 37 was improved from 71% 28 to 83% using their system (Scheme 12). The authors suggested that the role of NMI could be that of a nucleophile as well as an acid, indicating that the electronically neutral phosphomorpholidate could be substituted by NMI to form a cationic phosphor-Nmethylimidazolide intermediate. Upon addition of NMI they supportively observed a downfield shift in the 31 P NMR resonance of UMP-morpholidate.
Scheme 12.
Chemical synthesis of UDP-GalNAz 37 using NMI in place of 1-H-tetrazole. i) NMI⋅HCl, UMPmorpholidate, DMF, 12 h; ii) NaOMe, MeOH.
Following their description of a new class of allosteric galactosyltransferase inhibitors 33, 34 and a requirement to further develop the robustness of the synthetic protocols that afford essential precursors thereto, Wagner et al 35 investigated the synthesis of 5''-substituted UDP-sugars using a UMP-phosphoromorpholidate and NMI as promoter, as developed by Kahne. 32 Pleasingly, the group could apply the results of this work for their synthesis of both 5''-I-UDP-Gal 38 and 5''-I-UDP-GlcNAc 39 in good yields using DMF as solvent and with a reaction time of only 8 h (Scheme 13). Subsequent Suzuki-Miyaura coupling with 5-formylthien-2-yl boronic acid was successful for both 38 and 39 and allowed the biological evaluation of sugar-nucleotide mimetics 40 and 41 against the GlcNAc transferase GnT-V. The group have also used a phosphomorpholidate/1-H-tetrazole approach to access 5''-substituted-UDP-Gal mimetics and an anomeric C-glycosidic analogue. Additionally, the group described the first synthetic route to prepare 5''-CF 3 -UDPGlc 42 and 5''-CF 3 -UDP-Gal 43 directly from the corresponding 5''-unsubstituted UDPsugars in a one-step reaction (Scheme 14). Using a control experiment with UMP 5'-phosphoromorpholidate, the group showed that the reactivity of their piperidate analogues 46 and 47 reduced the time required for pyrophosphorylation from 28 days to 5 days using 1-H-tetrazole promotion, suggesting that the higher pK aH of piperdine (relative to morpholine) increased the rate of acid promoted activation required for reaction. They then sought to screen a series of weakly acidic activation systems, to further reduce the reaction times associated with using 1-H-tetrazole. Of the compounds investigated, DCI and N-methylimidazolium chloride showed the best reduction in comparable reaction time (12 h) with similar yields, but the lower hydroscopicity and better solubility in organic solvents prompted them to favour DCI. The uridine-5'-phosphoropiperidates were then coupled with 6-deoxy-L-sugar-1-phosphates 2 and 3 using DCI as activator. A representative example to deliver UDP-α-L-rhamnose 48 is shown in Scheme 16. This work suggests that DCI-promoted-nucleoside phosphoropiperidate pyrophosphorylation is a system that improves upon more traditional approaches, however, its general applicability across a broader substrate scope is still to be established. Jacobson and co-workers 39 recently synthesized a range of UDP-α-D-Glc derivatives to build an SAR profile and probe the physiological function for endogenous ligand binding to the P2Y 14 receptor: a ligand-gated nucleotide signaling protein that plays a role in the neuroimmune system. The group synthesized several derivatives to probe the effect of modification on the heterocyclic U base, ribose ring and Glc residue. When focusing upon Glc, they constructed several deoxy-fluoro mimetics, GlcA and C-2 or C-6 linked sugarnucleotides. In most examples, the group adopted the Khorana-UMP-morpholidate strategy along with the tetra-N-butyl ammonium salt form of the relevant sugar-1-P. However, in the case of U modified species the group switched to using CDI 40 activation of the modified nucleoside monophosphate, followed by diphosphate coupling.
Finally, the Liu group 15 completed their impressive chemical synthesis of GDP-α-Doctose 49 using Khorana's phosphomorpholidate approach, delivering the material in 19% yield (Scheme 17) . 
Pyrophosphorylation using phosphorimidazolides
Hindsgaul et al 29 established a one-pot synthetic approach to form sugar-nucleotides in water that required only a sequential addition of commercially available materials and could harness the crude reaction product as a donor for immediate use in glycosyltransferasemediated synthesis. The workers showed that reaction of DMC 49 with imidazole readily gave ImIm 50 and reasoned then whether 50 could subsequently activate a nucleotide monophosphate to its phosphorimidazolide to effect pyrophosphorylation (Scheme 18). Subsequently the group examined the capability of 52 to form a series of sugarnucleotides 53-56 (Scheme 19). Finally, they utilised the crude and chemically benign reaction solutions containing the sugar-NDP as requisite donors in a series of chemoenzymatic oligosaccharide syntheses. Overall, this work aimed to offer a solution for the production and utilisation of sugar-nucleotides for those without a prior expertise in the manipulation of sugar protecting groups and in performing moisture sensitive reactions. All the reagents are commercially available and provided the timing of their addition to the reaction is carefully monitored, the desired sugar-nucleotides can be accessed and used immediately as requisite donors. The Lowary group 20 has successfully adopted this procedure to synthesise UDP-GalfNAc and UDP-GalfN 3 , reporting both sugar-nucleotides in modest yields (16% and 23% respectively) although these were comparable to previously reported yields for similar substrates. Jemielity's group 30 described a protecting group free, magnesium chloride-promoted synthesis of sugar-nucleotides from the corresponding nucleoside 5
' -phosphorimidazolides and sugar 1-Ps in DMF (Scheme 20). Working on a consensus that phosphorimidazole-directed sugar-nucleotide synthesis is not accelerated by acid catalysis (i.e. 1-H-tetrazole), the group investigated the use of Lewis acid-promoted pyrophosphorylation. Their work demonstrated improvements to sugarnucleotide formation as follows: the addition of a metal chloride (ZnCl 2 or MgCl 2 ) significantly improved the solubility of the reagents, which otherwise are generally poorly soluble in DMF; the Lewis acid acting as a catalyst, activating imidazole as a leaving group and coordinating both reaction partners to form the diphosphate. The optimal reaction rate enhancement was achieved using 2 to 4 equivalents of MgCl 2 and any further addition retarded the rate, possibly through excessive coordination of the sugar-1-P, by Mg 2+ , decreasing its nucleophilicity.
They applied their technology to a range of different nucleoside 5'-phosphorimidazolides (A, G and U-containing) and sugar-1-P pairings (1-Glc, 1-Gal, 1-Fuc) obtaining good isolated yields (63-92%) and observing a significant reduction in reaction times (as low as 10 min. for GDP-α-D-Glc 57, Scheme 20) on small scale. Notably, when the scale was increased, to 100 mg for 57, the reaction time increased to 3 h, suggesting that the This method was successfully adopted by Vincent et al 23 for their synthesis of ADP-6-azido-6-deoxy-β-D-mannose (in 90% yield) and for construction of sulfonylated phosphono-exo-glycal sugar-nucleotide mimetics 58 and 59 (Scheme 21). 41 Here the authors noted that the Lewis acidic coupling conditions promoted an isomerisation of the exo-double bond in 59, delivering the mimetic sugar-nucleotide as a separable E/Z mixture. Taylor et al 42 reported a rapid and high yielding approach for preparing sugarnucleotides 61-64 which obviated the commonly encountered protection/deprotection requirements of the donor and acceptor (Scheme 22). Sulfonylimidazolium salt 60 was used as the key reagent to activate the NMP component before reaction with a sugar-1-P. The authors reasoned that reaction between the negatively charged phosphate moiety and the positively charged sulfonylimidazolium salt afforded the donor before any competing reaction with other nucelophilic substrate functional groups. They also suggested that the coupling step could proceed either via a mixed P/S anhydride intermediate or an imidazolium species formed from initial reaction of 60 with a NMP, followed by substitution by NMI. Symmetrical dinucleoside diphosphate formation via dimerization was suppressed by using DIPEA instead of NMI and the authors also commented that any unreacted NMP could be removed after pyrophosphorylation using alkaline phosphatase, improving purification efficiency. 
Pyrophosphorylation using activated phosphate esters
Meier et al 43 recently utilised their cycloSal technology 44, 45 on solid-support (Scheme 23), immobilising cycloSal-nucleotides via a succimidyl tether (through the furanose C3'-OH) onto an amino-methyl polystyrene resin. In a second step, the target molecules were delivered through reaction of the immobilized cycloSal-triester with a series of nucleophilic phosphate sources, followed by the cleavage from the resin. This technology provided a general access to nucleoside di-and triphosphates, sugar nucleotides and dinucleoside diphosphates. Their method delivered the materials in high overall purity, as the impurities from the phosphate nucleophile (which are generally problematic to remove via RPchromatographic or ion-exchange systems) could be removed prior to cleavage from the resin. To access NDP-sugars the group demonstrated synthesis of TDP-β-D-glucose 65, UDP-β-D-glucose 66 and TDP-α-D-galactose 67 (Scheme 24). Following cleavage from the resin compounds 65-67 were isolated in very good purity (78% for 65 and 66). In the case of TDP-α-D-galactose 67 the isolated purity was lower (43%) as the group observed that the conditions used to effect resin cleavage caused the formation of the 1,2-cyclic phosphate derivative of α-Gal and TMP.
The group also recently extended their previously reported solution-phase cycloSal methodology 44, 45 to access rare and non-natural NDP-sugars, including those containing glucose-6-sulfate, L-galactose and 2-fluoro-2-deoxyglycopyranosides. 16 These results, along with synthesis using the solid phase approach to sugar-nucleotides, are summarised in Table  2 . Ref. Table 2 . Summary of sugar-nucleotides accessed using activated cycloSal phosphate ester systems.
Sugar-nucleotides from nucleoside diphosphates and sugar electrophiles
Daniellou and co-workers 46 recently introduced a short and versatile chemical synthesis for both anomers of UDP-6-NHAc-6-deoxy-Galf (Scheme 25). The group were seeking to provide structure-function tools and potential inhibitor candidates for the lipophosphoglycan pathway in the parasite Leishmania, specifically concerning the activity of the galactofuranosyl transferase and UGM, for which UDP-Galf is the natural substrate. To do this, the group utilised 2-mercaptobenzimidazole furanose donor 68 in a direct diphosphate-forming glycosylation with the acidic form of UDP. Whilst this reaction was (expectedly) not diastereoselective, both anomers, 69 and 70, of UDP-6-NHAc-6-deoxy-Galf could be isolated in mg quantitates using semi-preparative RP-HPLC. Interestingly, the nonnative 1,2-trans sugar-nucleotide mimetic 70 was the more proficient in retarding the growth of L. donovani promastigotes in vitro. 
Diphosphate formation using a P
III -P V approach
Hergenrother et al 47 applied two different diphosphate-forming approaches in their synthesis of dimeric ADP-ribose 74 (Scheme 26). Firstly, the group used H-phosphonate 71 to couple with protected-AMP, an adaptation of the Atherton-Todd reaction, 48 suggesting that pyrophosphorylation occurs once the H-phosphonate has undergone oxidative chlorination with NCS to afford a chlorophosphate. Attempts to repeat this methodology to install a second pyrophosphate within 72 were unsuccessful and the group instead used phosphorimidazolide conditions (CDI, ZnCl 2 ) to effect coupling with 73, delivering dimeric ADP-ribose 74 in 61%, following deprotection. The group also applied this modification for the synthesis of mono-ADP-ribosylated peptides 10c and extended their P III -P V approach for the synthesis of methylene bisphosphonates, replacing the diphosphate linking oxygen with CH 2 and opening a route to mimetic methylene bisphosphonates of ADP, ATP, ADPR and FAD. 10 
Summary and outlook
Since the last review concerning the synthesis of sugar-nucleotides, there have been significant developments within this key branch of synthetic carbohydrate chemistry. Of particular note is advance in the number of chemical methods now available to access the crucial precursors, sugar-1-phosphates, across a range of monosaccharide systems, inclusive of mimetic and rare sugars. Reaction yields have generally improved and, perhaps more importantly, alternate conditions delivered (to the classically acidic environment used for phosphate introduction), opening new avenues for pre-modification of the sugar component.
Towards the central sugar-nucleotide forming reaction, the use of established phosphomorpholidate-activation chemistry is still commonplace. Activation is frequently accomplished using 1-H-tetrazole, however NMI has shown promise on a small number of mimetic examples. The emergence of a phosphorimidazolide-activation strategy (using Lewis acids or DMC as activator) provides a second nucleoside monophosphate derivative which has proven its capability on a number of examples in several laboratories. Perhaps most notable with this activation method is its use to access a broader pool of nucleoside components (ADP, GDP, UDP), compared with the classical morpholidate strategy (UDP only). This observation should be taken in context however, as the most common synthetic sugar-nucleotide targets are UDP-hexopyranose systems; particularly non-native species where the inclusion of one or multiple ring fluorine atoms and heterocycle base modifications confirms the necessity for robust chemical methodologies to address carbohydrate-based tools not accessible using chemoenzymatic strategies.
In conclusion, advances centered around P V -P V coupling chemistries mean that whilst a general synthetic protocol towards any sugar-nucleotide remains ever elusive, there is a robust and diverse body of synthetic possibilities capable of addressing access to a significant number of both native and mimetic structures. We hope that this key area of glycochemistry will continue to explore and deliver innovative new strategies for synthesising this essential class of biomolecule. 
